Dr. Stuart Goldstein

Company: MediBeacon Inc./ Cincinnati Children’s Hospital Medical Center

Job title: Director of Clinical Development, Professor of Pediatrics | Division of Nephrology & Hypertension

Bio:

Stuart L Goldstein, MD, is the Clark D West Endowed Chair, Professor of Pediatrics and Director, Center for Acute Care Nephrology at Cincinnati Children’s Hospital Medical Center. He received his medical degree from Columbia University, completed his pediatric residency at Baylor College of Medicine in Houston, Texas, and completed both clinical and research fellowships in pediatric nephrology at the Children’s Hospital in Boston, Massachusetts and is Founder and Principal Investigator for the Prospective Pediatric AKI Research Group, which conducted the largest multinational prospective AKI study in children, AWARE, results of which have been published in the New England Journal of Medicine. He has evaluated novel urinary AKI biomarkers in the pediatric critical care setting. He was one of two pediatric work group members for the KDIGO International AKI Guideline Work Group. He has led a multicenter national effort to reduce nephrotoxic AKI in children. He has also led the clinical studies for two AKI related medical devices, the Selective Cytopheretic Device and the diagnostic test NGAL both of which have received clearance from the FDA for marketing in children.

He has written over 400 journal articles, served as an Editor for two pediatric nephrology related textbooks and contributed book chapters to numerous texts including, Critical Care Nephrology, Evidence-Based Nephrology, Handbook of Dialysis Therapy, Management of Acute Kidney Problems, Pediatric Critical Care, Pediatric Nephrology, and Pediatric Nephrology in the ICU.

Seminars:

GFR Assessment at the Point of Care: Future transdermal GFR (tGFR) applications in the Clinic 9:00 am

Overview of the Transdermal GFR System (TGFR) including review of the transdermal GFR (tGFR) methodology, indication for use and patient care path Retrospective analysis of mGFR (relmapirazin) and tGFR data as it compares to the Standard of Care in current clinical practice Focused clinical use cases including a description of the unmet medical need and…Read more

day: Day Two AM